Full Breakdown
Daniel Radcliffe Prioritizes Audience Consent in Broadway Return
3/4/2026, 12:11:01 PM
Overview of the Production
Daniel Radcliffe is set to star in the Broadway production of *Every Brilliant Thing*, a one-person show that runs for 13 weeks at the Hudson Theatre, starting February 21. Written by Duncan Macmillan and Jonny Donahoe, the play tells the story of a child who creates a list of "everything brilliant" to uplift their mother following her suicide attempt. The immersive nature of the performance includes opportunities for audience members to read items from the list aloud.
Emphasis on Audience Consent
In preparation for his return to Broadway, Radcliffe has made it clear that audience participation will be entirely voluntary. He stated, "Anyone attending my show will not be asked to participate unless you want to," addressing concerns about the on-stage seating option that allows for a closer view of the performance. Radcliffe emphasized that even if audience members are selected to participate, they will be "thoroughly asked" for consent, ensuring that no one feels awkward or embarrassed during the show.
Thematic Significance
Radcliffe described *Every Brilliant Thing* as a "fun and interesting" theatrical experience that carries an important message. He noted, "I'm not saying this show saves lives, but this show wants people to stay alive," highlighting the play's potential impact on audiences. The focus on mental health and the importance of open conversations surrounding it is a central theme of the production.
Official Statements & Responses
Radcliffe's commitment to audience consent reflects a broader trend in theater to prioritize the comfort and safety of attendees. His statements aim to reassure potential viewers that the production is designed to be inclusive and respectful of personal boundaries. This approach aligns with ongoing discussions in the performing arts about the importance of consent and audience engagement.
Criticism & Opposition
While Radcliffe's emphasis on consent has been generally well-received, some critics argue that the immersive nature of the play may still create discomfort for certain audience members. Concerns have been raised about the potential for unexpected participation, even with consent protocols in place. However, Radcliffe's proactive stance aims to mitigate these concerns by clearly communicating the show's intentions.
What's Next
As *Every Brilliant Thing* approaches its opening date, Radcliffe's focus on audience consent will likely continue to be a topic of discussion within the theater community. The production's unique approach to engagement may set a precedent for future performances, emphasizing the importance of creating a safe and supportive environment for all attendees.
